Comorbid Obesity and Depression With an Anti-inflammatory Medication

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions

ObesityMajor Depressive DisorderInflammation

Interventions

DRUG

Minocycline 200mg

Dosage: 2x100mg/daily for 8 weeks

Trial Locations (1)

RECRUITING

King's College London, London

All Listed Sponsors

collaborator

South London and Maudsley NHS Foundation Trust

OTHER

lead

King's College London

OTHER